Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling

Abstract Expression of the low-density lipoprotein receptor (LDLR) has been shown to play a critical role in hypercholesterolemia-associated breast cancer growth and is associated with shorter recurrence-free survival in human breast cancer studies. We sought to identify how circulating LDL choleste...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tiffany Scully, Nathan Kase, Emily J. Gallagher, Derek LeRoith
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4637f21548d947e5b1af8ade15841430
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4637f21548d947e5b1af8ade15841430
record_format dspace
spelling oai:doaj.org-article:4637f21548d947e5b1af8ade158414302021-12-02T17:19:15ZRegulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling10.1038/s41598-021-97327-y2045-2322https://doaj.org/article/4637f21548d947e5b1af8ade158414302021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97327-yhttps://doaj.org/toc/2045-2322Abstract Expression of the low-density lipoprotein receptor (LDLR) has been shown to play a critical role in hypercholesterolemia-associated breast cancer growth and is associated with shorter recurrence-free survival in human breast cancer studies. We sought to identify how circulating LDL cholesterol and tumor LDLR might accelerate oncogenic processes by determining whether increased LDLR expression and cholesterol uptake are associated with the activation of the epidermal growth factor receptor (EGFR) signaling pathway in triple negative breast cancer (TNBC) cell lines. EGF stimulation of MDA-MB-468 (MDA468) cells activated p44/42MAPK (MAPK), increased expression of LDLR, and fluorescent LDL cholesterol uptake. However, stimulation of MDA-MB-231 (MDA231) cells with EGF did not lead to increased expression of LDLR despite inducing phosphorylation of EGFR. Inhibition of MAPK using UO126 in MDA231 cells reduced LDLR expression, and in MDA468 cells, UO126 impaired the LDLR increase in response to EGF. MDA468 cells exposed to the transcription inhibitor, Actinomycin, prior to treatment with EGF showed reduced degradation of LDLR mRNA compared to vehicle-treated cells. Our results suggest that the EGF-associated increase in LDLR protein expression is cell line-specific. The common pathway regulating LDLR expression was MAPK in both TNBC cell lines.Tiffany ScullyNathan KaseEmily J. GallagherDerek LeRoithNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Tiffany Scully
Nathan Kase
Emily J. Gallagher
Derek LeRoith
Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling
description Abstract Expression of the low-density lipoprotein receptor (LDLR) has been shown to play a critical role in hypercholesterolemia-associated breast cancer growth and is associated with shorter recurrence-free survival in human breast cancer studies. We sought to identify how circulating LDL cholesterol and tumor LDLR might accelerate oncogenic processes by determining whether increased LDLR expression and cholesterol uptake are associated with the activation of the epidermal growth factor receptor (EGFR) signaling pathway in triple negative breast cancer (TNBC) cell lines. EGF stimulation of MDA-MB-468 (MDA468) cells activated p44/42MAPK (MAPK), increased expression of LDLR, and fluorescent LDL cholesterol uptake. However, stimulation of MDA-MB-231 (MDA231) cells with EGF did not lead to increased expression of LDLR despite inducing phosphorylation of EGFR. Inhibition of MAPK using UO126 in MDA231 cells reduced LDLR expression, and in MDA468 cells, UO126 impaired the LDLR increase in response to EGF. MDA468 cells exposed to the transcription inhibitor, Actinomycin, prior to treatment with EGF showed reduced degradation of LDLR mRNA compared to vehicle-treated cells. Our results suggest that the EGF-associated increase in LDLR protein expression is cell line-specific. The common pathway regulating LDLR expression was MAPK in both TNBC cell lines.
format article
author Tiffany Scully
Nathan Kase
Emily J. Gallagher
Derek LeRoith
author_facet Tiffany Scully
Nathan Kase
Emily J. Gallagher
Derek LeRoith
author_sort Tiffany Scully
title Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling
title_short Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling
title_full Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling
title_fullStr Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling
title_full_unstemmed Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling
title_sort regulation of low-density lipoprotein receptor expression in triple negative breast cancer by egfr-mapk signaling
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/4637f21548d947e5b1af8ade15841430
work_keys_str_mv AT tiffanyscully regulationoflowdensitylipoproteinreceptorexpressionintriplenegativebreastcancerbyegfrmapksignaling
AT nathankase regulationoflowdensitylipoproteinreceptorexpressionintriplenegativebreastcancerbyegfrmapksignaling
AT emilyjgallagher regulationoflowdensitylipoproteinreceptorexpressionintriplenegativebreastcancerbyegfrmapksignaling
AT derekleroith regulationoflowdensitylipoproteinreceptorexpressionintriplenegativebreastcancerbyegfrmapksignaling
_version_ 1718381023880806400